Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D in COVID-19 (COVID-VIT-D)
NCT04552951Phase 4Unknown
- Sponsor
- FINBA
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vitamin d in coronavirus disease 2019 (COVID-19), sponsored by FINBA. Primary endpoints: Mortality at 12 days, Admission to Intensive Care Unit at 12 days and 1 more. Status: unknown.
02
Drugs
vitamin d
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04552951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04552951.